Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank79
3Y CAGR+141.6%
5Y CAGR+21.2%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+141.6%/yr
vs -51.5%/yr prior
5Y CAGR
+21.2%/yr
Recent acceleration
Acceleration
+193.1pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.95M | -58.2% |
| 2024 | $7.05M | +172.5% |
| 2023 | $-9.73M | -4757.9% |
| 2022 | $209000.00 | +105.0% |
| 2021 | $-4.21M | -472.6% |
| 2020 | $1.13M | -46.2% |
| 2019 | $2.10M | -44.3% |
| 2018 | $3.77M | +1343.3% |
| 2017 | $261000.00 | -92.5% |
| 2016 | $3.47M | - |